1.
Fairfield H, Srivastava A, Ananda G, Liu R, Kircher M, Lakshminarayana A, Harris BS,
Karst SY, Dionne LA, Kane CC et al. Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian
disorders. Genome Res. 2015;25(7):948-957.
2.
Prows DR, Klingler A, Gibbons Jr. WJ, Homan SM, Zimmermann N. Characterization of
a mouse model of hypereosinophilia-associated heart disease. Am J Physiol Heart Circ
Physiol. In Press.
3.
Gervais F, Desforges C, Skamene E. The C5-sufficient A/J congenic mouse strain. Inflammatory
response and resistance to Listeria monocytogenes. J Immunol. 1989;142(6):2057-2060.
4.
Jagannath C, Hoffmann H, Sepulveda E, Actor JK, Wetsel RA, Hunter RL. Hypersusceptibility
of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement
component (C5). Scand J Immunol. 2000;52(4):369-379.
5.
Mullick A, Leon Z, Min-Oo G, Berghout J, Lo R, Daniels E, Gros P. Cardiac failure
in C5-deficient A/J mice after Candida albicans infection. Infect Immun. 2006;74(8):4439-4451.
6.
Tuite A, Elias M, Picard S, Mullick A, Gros P. Genetic control of susceptibility to
Candida albicans in susceptible A/J and resistant C57BL/6J mice. Genes Immun. 2005;6(8):672-682.
7.
Baumann U, Chouchakova N, Gewecke B, Kohl J, Carroll MC, Schmidt RE, Gessner JE. Distinct
tissue site-specific requirements of mast cells and complement components C3/C5a receptor
in IgG immune complex-induced injury of skin and lung. J Immunol. 2001;167(2):1022-1027.
8.
Hawlisch H, Kohl J. Complement and Toll-like receptors: key regulators of adaptive
immune responses. Mol Immunol. 2006;43(1-2):13-21.
9.
Heller T, Gessner JE, Schmidt RE, Klos A, Bautsch W, Kohl J. Cutting edge: Fc receptor
type I for IgG on macrophages and complement mediate the inflammatory response in
immune complex peritonitis. J Immunol. 1999;162(10):5657-5661.
10.
Morgan BP, Harris CL. Complement, a target for therapy in inflammatory and degenerative
diseases. Nat Rev Drug Discov. 2015;14(12):857-877.
11.
Pandey MK, Grabowski GA. Immunological cells and functions in Gaucher disease. Crit
Rev Oncog. 2013;18(3):197-220.
12.
Wetsel RA, Fleischer DT, Haviland DL. Deficiency of the murine fifth complement component
(C5). A 2-base pair gene deletion in a 5'-exon. J Biol Chem. 1990;265(5):2435-2440.
13.
Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, Watkins SC, Cox GA, Brown
RH, Jr. Disruption of muscle membrane and phenotype divergence in two novel mouse
models of dysferlin deficiency. Hum Mol Genet. 2004;13(18):1999-2010.
14.
Bittner RE, Anderson LV, Burkhardt E, Bashir R, Vafiadaki E, Ivanova S, Raffelsberger
T, Maerk I, Hoger H, Jung M et al. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle
muscular dystrophy 2B. Nat Genet. 1999;23(2):141-142.
15.
Kobayashi K, Izawa T, Kuwamura M, Yamate J. Dysferlin and animal models for dysferlinopathy.
J Toxicol Pathol. 2012;25(2):135-147.
16.
Broman KW, Sen S: A guide to QTL mapping with R/qtl. New York: Springer; 2009.
17.
Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses.
Bioinformatics. 2003;19(7):889-890.
18.
Morgan AP. argyle: An R package for analysis of Illumina genotyping arrays. G3 (Bethesda).
2015;6(2):281-286.
19.
Kuijpers TW, Tool ATJ, van der Bijl I, de Boer M, van Houdt M, de Cuyper IM, Roos
D, van Alphen F, van Leeuwen K, Cambridge EL et al. Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B
deficiency. J Allergy Clin Immunol. 2017;140(1):273-277 e210.
20.
Hall DD, Ponce JM, Chen B, Spitler KM, Alexia A, Oudit GY, Song LS, Grueter CE. Ectopic
expression of Cdk8 induces eccentric hypertrophy and heart failure. JCI Insight. 2017;2(15).
21.
Mei L, Huang Y, Lin J, Chu M, Hu C, Zhou N, Wu L. Increased cardiac remodeling in
cardiac-specific Flt-1 receptor knockout mice with pressure overload. Cell Tissue
Res. 2015;362(2):389-398.
22.
Pfister O, Lorenz V, Oikonomopoulos A, Xu L, Hauselmann SP, Mbah C, Kaufmann BA, Liao
R, Wodnar-Filipowicz A, Kuster GM. FLT3 activation improves post-myocardial infarction
remodeling involving a cytoprotective effect on cardiomyocytes. Journal of the American
College of Cardiology. 2014;63(10):1011-1019.
23.
D'Agostino M, Tornillo G, Caporaso MG, Barone MV, Ghigo E, Bonatti S, Mottola G. Ligand
of Numb proteins LNX1p80 and LNX2 interact with the human glycoprotein CD8alpha and
promote its ubiquitylation and endocytosis. J Cell Sci. 2011;124(Pt 21):3545-3556.
24.
Norum HM, Gullestad L, Abraityte A, Broch K, Aakhus S, Aukrust P, Ueland T. Increased
serum levels of the Notch ligand DLL1 are associated with diastolic dysfunction, reduced
exercise capacity, and adverse outcome in chronic heart failure. J Card Fail. 2016;22(3):218-223.
25.
Apostolidis SA, Rodriguez-Rodriguez N, Suarez-Fueyo A, Dioufa N, Ozcan E, Crispin
JC, Tsokos MG, Tsokos GC. Phosphatase PP2A is requisite for the function of regulatory
T cells. Nat Immunol. 2016;17(5):556-564.
26.
Jain M, Jakubowski A, Cui L, Shi J, Su L, Bauer M, Guan J, Lim CC, Naito Y, Thompson
JS et al. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in
the development of cardiac dysfunction and failure. Circulation. 2009;119(15):2058-2068.
27.
Shahini N, Michelsen AE, Nilsson PH, Ekholt K, Gullestad L, Broch K, Dahl CP, Aukrust
P, Ueland T, Mollnes TE et al. The alternative complement pathway is dysregulated in patients with chronic heart
failure. Sci Rep. 2017;7:42532.
28.
Selli ME, Thomas AC, Wraith DC, Newby AC. A humanized HLA-DR4 mouse model for autoimmune
myocarditis. J Mol Cell Cardiol. 2017;107:22-26.
29.
Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM. Cardiac-specific overexpression
of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. J Card
Fail. 1997;3(2):117-124.
30.
Benschop R, Wei T, Na S. Tumor necrosis factor receptor superfamily member 21: TNFR-related
death receptor-6, DR6. Adv Exp Med Biol. 2009;647:186-194.
31.
Ogbogu PU, Rosing DR, Horne MK, 3rd. Cardiovascular manifestations of hypereosinophilic
syndromes. Immunol Allergy Clin North Am. 2007;27(3):457-475.
32.
Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogue B, Gross
W, Holle J et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task
Force recommendations for evaluation and management. Eur J Intern Med. 2015;26(7):545-553.
33.
Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, Richard I, Marchand
S, Bourg N, Argov Z et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated
in limb-girdle muscular dystrophy type 2B. Nat Genet. 1998;20(1):37-42.
34.
Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati
F, Hamida MB et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb
girdle muscular dystrophy. Nat Genet. 1998;20(1):31-36.
35.
Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP.
Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature. 2003;423(6936):168-172.
36.
Chase TH, Cox GA, Burzenski L, Foreman O, Shultz LD. Dysferlin deficiency and the
development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.
Am J Pathol. 2009;175(6):2299-2308.
37.
Han R, Bansal D, Miyake K, Muniz VP, Weiss RM, McNeil PL, Campbell KP. Dysferlin-mediated
membrane repair protects the heart from stress-induced left ventricular injury. The
Journal of clinical investigation. 2007;117(7):1805-1813.
38.
Lammerding J, Lee RT. Torn apart: membrane rupture in muscular dystrophies and associated
cardiomyopathies. The Journal of clinical investigation. 2007;117(7):1749-1752.
39.
Gangaplara A, Massilamany C, Brown DM, Delhon G, Pattnaik AK, Chapman N, Rose N, Steffen
D, Reddy J. Coxsackievirus B3 infection leads to the generation of cardiac myosin
heavy chain-alpha-reactive CD4 T cells in A/J mice. Clin Immunol. 2012;144(3):237-249.
40.
Radovanovic I, Mullick A, Gros P. Genetic control of susceptibility to infection with
Candida albicans in mice. PLoS One. 2011;6(4):e18957.
41.
Leon JS, Godsel LM, Wang K, Engman DM. Cardiac myosin autoimmunity in acute Chagas'
heart disease. Infect Immun. 2001;69(9):5643-5649.
42.
Wang C, Wong J, Fung G, Shi J, Deng H, Zhang J, Bernatchez P, Luo H. Dysferlin deficiency
confers increased susceptibility to coxsackievirus-induced cardiomyopathy. Cell Microbiol.
2015;17(10):1423-1430.
43.
Hirasawa M, Kitaura Y, Deguchi H, Ukimura A, Kawamura K. Spontaneous myocarditis in
DBA/2 mice. Light microscopic study with transmission and X-ray analytical electron
microscopic studies. Virchows Arch. 1998;432(5):461-468.
44.
Metcalf D, Alexander WS, Ryan PJ, Mifsud S, Di Rago L. Production of colony-stimulating
factors and IL-5 by organs from three types of mice with inflammatory disease due
to loss of the suppressor of cytokine signaling-1. J Immunol. 2001;167(8):4661-4667.
45.
Yoshida T, Fukuda T, Hatano M, Koseki H, Okabe S, Ishibashi K, Kojima S, Arima M,
Komuro I, Ishii G et al. The role of Bcl6 in mature cardiac myocytes. Cardiovasc Res. 1999;42(3):670-679.
46.
Barin JG, Baldeviano GC, Talor MV, Wu L, Ong S, Fairweather D, Bedja D, Stickel NR,
Fontes JA, Cardamone AB et al. Fatal eosinophilic myocarditis develops in the absence of IFN-gamma and IL-17A.
J Immunol. 2013;191(8):4038-4047.
47.
Jane-wit D, Yu M, Edling AE, Kataoka S, Johnson JM, Stull LB, Moravec CS, Tuohy VK.
A novel class II-binding motif selects peptides that mediate organ-specific autoimmune
disease in SWXJ, SJL/J, and SWR/J mice. J Immunol. 2002;169(11):6507-6514.
48.
Rabin ER, Hassan SA, Jenson AB, Melnick JL. Coxsackie Virus B3 Myocarditis in Mice.
An Electron Microscopic, Immunofluorescent and Virus-Assay Study. Am J Pathol. 1964;44:775-797.
49.
Hirasawa M, Deguchi H, Ukimura A, Kitaura Y. Immunologic interaction between infiltrating
eosinophils and T lymphocytes in murine spontaneous eosinophilic myocarditis. Int
Arch Allergy Immunol. 2003;130(1):73-81.
50.
Elliott JF, Liu J, Yuan ZN, Bautista-Lopez N, Wallbank SL, Suzuki K, Rayner D, Nation
P, Robertson MA, Liu G et al. Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic
IAbeta knockout NOD mice. Proc Natl Acad Sci U S A. 2003;100(23):13447-13452.
51.
Liu J, Purdy LE, Rabinovitch S, Jevnikar AM, Elliott JF. Major DQ8-restricted T-cell
epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null)
NOD mice. Diabetes. 1999;48(3):469-477.
52.
Taneja V, David CS. Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo
transgenic mice. J Autoimmun. 2009;33(3-4):260-269.
53.
Poffenberger MC, Shanina I, Aw C, El Wharry N, Straka N, Fang D, Baskin-Hill AE, Spiezio
SH, Nadeau JH, Horwitz MS. Novel nonmajor histocompatibility complex-linked loci from
mouse chromosome 17 confer susceptibility to viral-mediated chronic autoimmune myocarditis.
Circ Cardiovasc Genet. 2010;3(5):399-408.
54.
Nadeau JH, Singer JB, Matin A, Lander ES. Analysing complex genetic traits with chromosome
substitution strains. Nat Genet. 2000;24(3):221-225.
55.
Herskowitz A, Beisel KW, Wolfgram LJ, Rose NR. Coxsackievirus B3 murine myocarditis:
wide pathologic spectrum in genetically defined inbred strains. Hum Pathol. 1985;16(7):671-673.
56.
Prows DR, Gibbons WJ, Jr., Smith JJ, Pilipenko V, Martin LJ. Age and sex of mice markedly
affect survival times associated with hyperoxic acute lung injury. PLoS One. 2015;10(6):e0130936.
57.
Prows DR, Hafertepen AP, Winterberg AV, Gibbons WJ, Jr., Liu C, Nick TG. Genetic analysis
of hyperoxic acute lung injury survival in reciprocal intercross mice. Physiol Genomics.
2007;30(3):271-281.
58.
Morgan AP, Fu CP, Kao CY, Welsh CE, Didion JP, Yadgary L, Hyacinth L, Ferris MT, Bell
TA, Miller DR et al. The Mouse universal genotyping array: From substrains to subspecies. G3 (Bethesda).
2015.
59.
Doerge RW, Churchill GA. Permutation tests for multiple loci affecting a quantitative
character. Genetics. 1996;142(1):285-294.